4
Changes in Ownership
Oncotelic Therapeutics, Inc. Filed Acc 0001209191-18-039169
Options or other derivatives
- Chief Financial Officer acquired 750,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/doc4.xml…